The Company

Eucardia develops the Heart Damper, a novel medical device intended to provide a simple, quick and cost-effective solution to treat patients affected by Advanced Heart Failure, giving them a longer and better life expectancy, at the same time reducing healthcare costs for their assistance.

Eucardia is an innovative SME operating since 2014, which attracts and aggregates experts with diversified and complementary skills in the fields of experimental and clinical research, cardiology and cardiosurgery, biomedical and materials engineering, regulatory affairs, development and management of highly technological businesses.

  • 01 Eucardia is an innovative SME
  • 02 It develops a revolutionary cardiac device
  • 03 It counts on a constantly growing team of experts with diversified and complementary skills

Our core team

Eucardia’s ambitious project, by becoming a mission, has managed to involve a motivated and cohesive team, strongly convinced that technology, today, allows us to solve a pressing medical problem such as Systolic Heart Failure.

Roberto Parravicini

Scientific Director

Read bio

Marco Bottaro

Chief Executive Officer

Read bio

Jim Pokorney

Chief Technical Advisor

Read bio

Edoardo Tronchet

Regulatory Affairs Manager

Read bio

Francesca Parravicini

Investor Relations & Corporate Communications

Read bio

Emanuele Ottina

Head of Finance and Fundraising

Read bio

Board of Scientific Advisors

Eucardia’s project has the support and endorsement of distinguished medical professionals, who believe in the potential of the Heart Damper to the point of sharing with the company their extraordinary clinical, academic and research experience.

Claudio Bussadori

Cardiovascular specialist
Veterinary Clinic Director

Read bio

Giancarla Cerioli

Clinical cardiologist

Read bio

Jacques Goldstein

Cardiac surgeon

Read bio

Endorsement

The important awards and endorsements obtained by Eucardia at both national and international level confirm the highly innovative impact of the project.